ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,375Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 1000

$901K Total Retail Price of All Prescriptions

Rank: 75 out of 1000

765 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 765 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

31% of this provider’s 765 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 15,550 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,181 626 S3 1 1
LISINOPRIL 816 544 2 5
POTASSIUM CHLORIDE 602 509 3 10
SIMVASTATIN 597 433 4 3
AMLODIPINE BESYLATE 584 480 5 6
OMEPRAZOLE 565 426 6 2
FUROSEMIDE 531 437 7 7
RANITIDINE HCL 515 344 8 37
LEVOTHYROXINE SODIUM 514 376 9 4
TRAMADOL HCL 439 228 10 13
WARFARIN SODIUM 436 364 11 22
METFORMIN HCL 424 257 12 8
HYDROCHLOROTHIAZIDE 379 270 13 9
GLYBURIDE 355 241 R 14 92
METOPROLOL TARTRATE 349 238 15 19
CITALOPRAM HBR 317 216 16 17
SERTRALINE HCL 297 194 17 26
ZOLPIDEM TARTRATE 280 181 18 16
ALLOPURINOL 254 173 19 31
METOPROLOL SUCCINATE 247 201 20 21
DIGOXIN 230 202 21 52
BUMETANIDE 222 186 22 112
LOSARTAN POTASSIUM 213 173 23 25
AZITHROMYCIN 199 121 24 36
LOSARTAN-HYDROCHLOROTHIAZIDE 198 132 25 38
LYRICA 185 80 26 47
CLONIDINE HCL 182 128 27 27
BYSTOLIC 180 117 28 126
AMITRIPTYLINE HCL 178 80 R 29 45
NEXIUM 175 131 30 23
NIFEDIPINE ER 173 116 31 130
GABAPENTIN 172 113 32 11
NAMENDA 171 155 33 43
KLOR-CON 8 152 123 34 217
MIRTAZAPINE 151 135 35 56
PRAVASTATIN SODIUM 147 82 36 12
CLOPIDOGREL 146 125 37 35
ISOSORBIDE MONONITRATE ER 144 109 38 71
CEPHALEXIN 138 81 39 90
DOXAZOSIN MESYLATE 126 102 40 111
CRESTOR 122 90 41 30
SPIRIVA 119 96 42 64
ATORVASTATIN CALCIUM 117 86 43 18
GEMFIBROZIL 114 67 44 105
VENTOLIN HFA 112 43 45 83
TAMSULOSIN HCL 111 88 46 33
VERAPAMIL ER 109 64 47 86
DONEPEZIL HCL 108 108 48 32
TIZANIDINE HCL 108 23 48 76
CARVEDILOL 107 91 50 15
PLAVIX 94 84 51 49
NOVOLIN 70-30 92 73 52 160
PANTOPRAZOLE SODIUM 92 65 52 28
CIPROFLOXACIN HCL 91 75 54 46
METOCLOPRAMIDE HCL 89 55 55 99
PRAMIPEXOLE DIHYDROCHLORIDE 88 45 56 147
FLUTICASONE PROPIONATE 88 80 56 40
HYDRALAZINE HCL 87 77 58 74
ENALAPRIL MALEATE 87 81 58 58
COUMADIN 86 57 60 237
NITROGLYCERIN PATCH 86 81 60 226
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 41 62 20
CEFUROXIME 81 62 63 133
JANUVIA 81 46 63 85
RISPERIDONE 78 71 65 87
ADVAIR DISKUS 76 52 66 65
FENTANYL 76 74 S2 66 100
GLIMEPIRIDE 74 43 68 34
ESTRADIOL 74 29 R 68 114
ALENDRONATE SODIUM 74 67 68 57
DILTIAZEM 24HR CD 73 62 71 136
ESCITALOPRAM OXALATE 73 59 71 60
DIVALPROEX SODIUM 72 28 73 113
CYCLOBENZAPRINE HCL 71 14 R 74 39
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 42 74 70
SPIRONOLACTONE 71 51 74 78
TRAZODONE HCL 69 35 77 29
PREDNISONE 68 48 78 42
HUMULIN 70-30 68 30 78 131
BENZTROPINE MESYLATE 66 43 R 80 180
CEFADROXIL 65 36 81 270
PROMETHAZINE HCL 65 19 R 81 54
PAROXETINE HCL 65 53 81 63
RAMIPRIL 65 45 81 77
METFORMIN HCL ER 65 39 81 44
CARBAMAZEPINE 63 16 86 225
ONDANSETRON HCL 62 47 87 204
TRIAMCINOLONE ACETONIDE 62 33 87 159
NASONEX 59 41 89 240
PHENYTOIN SODIUM EXTENDED 59 17 89 115
DILTIAZEM ER 59 41 89 146
QUINAPRIL HCL 59 57 89 117
PROAIR HFA 58 25 93 50
GLIPIZIDE 57 49 94 62
NITROFURANTOIN 57 44 94 199
FLUOXETINE HCL 56 40 96 51
MOEXIPRIL HCL 54 28 97 432
SINGULAIR 54 28 97 84
NITROSTAT 54 38 97 266
LEVOFLOXACIN 53 40 100 73
MELOXICAM 53 36 100 14
ATENOLOL 52 37 102 24
INSULIN SYRINGE 52 15 102 93
POLYETHYLENE GLYCOL 3350 52 27 102 69
MECLIZINE HCL 52 47 102 80
DETROL LA 52 52 102 208
TRILIPIX 51 29 107 218
FENOFIBRATE 50 27 108 55
EVISTA 50 47 108 168
CILOSTAZOL 50 49 108 227
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.